Details for New Drug Application (NDA): 201993
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 201993
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Mylan Pharms Inc |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 201993
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 201993
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 201993 | ANDA | Mylan Pharmaceuticals Inc. | 0378-1403 | 0378-1403-96 | 12 TABLET in 1 BOTTLE, PLASTIC (0378-1403-96) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 201993 | ANDA | Mylan Pharmaceuticals Inc. | 0378-1404 | 0378-1404-96 | 12 TABLET in 1 BOTTLE, PLASTIC (0378-1404-96) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Dec 31, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Dec 31, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription